E-LIB Suche - Ergebnisse für: Jagannath, Sundar

1

Biomarker Correlates of 3 Year Response in Cartitude-1: A P..:

Lin, Yi ; Usmani, Saad Z. ; Berdeja, Jesús G...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S377 , 2024

2

Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (..:

Patel, Krina K. ; Rodríguez-Otero, Paula ; Nooka, Ajay K....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S322 , 2024

Link: https://doi.org/10.1016/..

3

Characterization of Infectious Complications during the Exp..:

Mihalyova, Jana ; Ahmad, Sana ; Handa, Shivani...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S181 , 2024

Link: https://doi.org/10.1016/..

4

Prevalence and impact of diabetes on survival of patients w..:

Shah, Urvi A. ; Moshier, Erin ; Derkach, Andriy...
Blood Advances. 8 (2024) 1 - p. 236-247 , 2024

Link: https://doi.org/10.1182/..

5

Cilta-cel, a BCMA-targeting CAR-T therapy for patients with..:

Jagannath, Sundar ; Jackson, Carolyn C. ; Schecter, Jordan M....
Expert Opinion on Biological Therapy. 24 (2024) 5 - p. 339-350 , 2024

Link: https://doi.org/10.1080/..

6

Optimizing the CAR T-Cell Therapy Experience in Multiple My..:

Ailawadhi, Sikander ; Shune, Leyla ; Wong, Sandy W....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 5 - p. e217-e225 , 2024

Link: https://doi.org/10.1016/..

7

Cost per Responder Analysis of Patients with Lenalidomide-R..:

Hansen, Doris K ; Lu, Xiaoxiao ; Castaneda, Omar...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S379 , 2024

Link: https://doi.org/10.1016/..

8

Regression of smoldering myeloma with treatment of Gaucher ..:

Barley, Kevin ; Parekh, Anshuman ; Salam, Syed...
Blood Advances. 8 (2024) 7 - p. 1634-1638 , 2024

Link: https://doi.org/10.1182/..

9

Comparing Bendamustine-Based Bridging to Standard Chemother..:

Leyfman, Yan ; Rajeeve, Sridevi ; Sheng, Tianxiang...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S386-S387 , 2024

Link: https://doi.org/10.1016/..

10

Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Pre..:

Mejia Saldarriaga, Mateo ; Pan, Darren ; Unkenholz, Caitlin...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

11

Phase 1 study combining elotuzumab with autologous stem cel..:

Coffey, David G ; Osman, Keren ; Aleman, Adolfo...
Journal for ImmunoTherapy of Cancer. 12 (2024) 4 - p. e008110 , 2024

Link: https://doi.org/10.1136/..

12

The effect of age and other patient characteristics on outc..:

Abonour, Rafat ; Lee, Hans C. ; Rifkin, Robert...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

13

P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS ..:

Abonour, Rafat ; Rifkin, Robert ; Ailawadhi, Sikander...
HemaSphere. 7 (2023) S3 - p. e52503e2 , 2023

Link: https://doi.org/10.1097/..

14

Treatment Patterns, Survival, Quality of Life, and Healthca..:

Lee, Hans C. ; Ramasamy, Karthik ; Weisel, Katja...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 2 - p. 112-122 , 2023

Link: https://doi.org/10.1016/..

15

P-175 Improving Anti-BCMA CAR-T functionality with novel im..:

Aleman, Adolfo ; Kogan-Zajdman, Ariel ; Upadhyaya, Bhaskar...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S131-S132 , 2023

Link: https://doi.org/10.1016/..